5 Key Takeaways

• 1

  Less than 25% of veterans with newly diagnosed HFrEF achieved quadruple therapy during a median follow-up of 2.9 years.

• 2

  The median time to achieve quadruple therapy was over 6 months, with 21% of patients reaching this treatment.

• 3

  Prescription copays were linked to lower rates of quadruple therapy, with priority group 1 patients having higher achievement rates.

• 4

  Adjusted rates of quadruple therapy were higher among Black and Hispanic patients compared to White patients.

• 5

  Inpatient diagnosis was associated with a 50% lower likelihood of achieving quadruple therapy within 6 months.